Solel Partners LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001790604

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHigh Turnover how tags are computed

Q2 2024 · 21 positions · Total reported value $594.04M · Top-10 concentration 75.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 64.0% · 6 new · 9 cut · 1 exited

Active Share (vs S&P 500): 95.3% · vs QQQ: 95.8% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +20.8% · vs SPY +6.0% · Prev Value $467.67M — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2024 13F filing, Solel Partners LP disclosed 21 equity positions with a combined reported value of $594.04M. The filing implies a focused portfolio: its ten largest positions account for 75.1% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.

The largest disclosed positions as of Q2 2024 were HUM ($74.66M), BIOX ($51.33M), SYF ($49.75M). By sector, the heaviest allocations are Consumer Discretionary 21.8%, Health Care 20.8%. Versus the prior quarter, allocation shifted toward Consumer Staples (+11.1pp), Consumer Discretionary (+1.4pp) and away from Financials (-0.6pp), Industrials (-1.7pp).

Versus the prior quarter, Solel Partners LP opened 6 new positions, trimmed 9 and fully exited 1, a turnover rate of 64.0% of positions. The portfolio's overlap with the prior quarter was 77% of names.

The largest new positions opened in Q2 2024 were BRSL ($43.48M), GO ($35.98M), CVS ($29.73M).

Of the 1 positions fully exited versus the prior quarter, the largest were ALIT ($31.20M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • BRSL BRIGHTSTAR LOTTERY PLC · $43.48M
  • GO GROCERY OUTLET HLDG CORP · $35.98M
  • CVS CVS HEALTH CORP · $29.73M
  • EVRI EVERI HLDGS INC · $488.12K

Fully Exited (vs previous quarter)

  • ALIT Alight Inc A · prev qtr: $31.20M

Insider Transactions (Form 4)

Latest Solel Partners LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Solel Partners LP is an SEC-registered 13F filer based in Boston, MA, United States. As of Q2 2026 it reported 24 US equity positions with a combined value of $588.49M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-117394 (status: Approved), registered 2019-09-26
  • Regulatory AUM (Form ADV): $1.24B as of 2026-03-24
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 24 positions · $588.49M reported value (Q2 2026)
  • Top 10 holdings = 72.6% of reported value
  • Largest position: HUM (HUMANA INC) at 11.0%
  • Average position size: $24.52M

Sector Tilt

  • Health Care 32.5%
  • Consumer Discretionary 27.9%
  • Financials 14.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 6 new, 5 added, 9 reduced, 1 exited
  • 4 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 20.8%
Financials 20.3%
Technology 7.5%
Other 10.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 199.80K $74.66M 12.57%
12.57%
Add
2 4.58M $51.33M 8.64%
8.64%
Hold
3 1.05M $49.75M 8.38%
8.38%
Hold
4 2.12M $43.48M 7.32%
7.32%
New
5 4.06M $40.30M 6.78%
6.78%
Add
6 202.47K $39.13M 6.59%
6.59%
Hold
7 789.00K $38.99M 6.56%
6.56%
Hold
8 111.20K $36.76M 6.19%
6.19%
Reduce
9 1.63M $35.98M 6.06%
6.06%
New
10 3.69M $35.53M 5.98%
5.98%
Add
11 787.32K $35.41M 5.96%
5.96%
Hold
12 503.40K $29.73M 5.00%
5.00%
New
13 416.40K $26.79M 4.51%
4.51%
Hold
14 883.14K $16.13M 2.71%
2.71%
Reduce
15 1.17M $12.15M 2.04%
2.04%
Hold
16 1.33M $9.91M 1.67%
1.67%
Add
17 1.49M $8.90M 1.50%
1.50%
Reduce
18 266.59K $4.88M 0.82%
0.82%
Reduce
19 4.09M $2.38M 0.40%
0.40%
Hold
20 65.60K $1.37M 0.23%
0.23%
Hold
21 58.11K $488.12K 0.08%
0.08%
New

FAQ

What did Solel Partners LP buy in 2024-Q2?

In its 2024-Q2 13F filing, Solel Partners LP reported 21 equity positions worth $594.04M in aggregate; its largest disclosed positions were HUM ($74.66M), BIOX ($51.33M), SYF ($49.75M).

How large is Solel Partners LP's portfolio?

Solel Partners LP reported $594.04M of long equity holdings across 21 positions as of 2024-Q2. Top-10 holdings account for 75.1% of reported value.

What is Solel Partners LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/solel-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →